1_J
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-13 21:12:06 UTC
Verified By
Rollup News
Johnson & Johnson has refined its use of generative AI after conducting 900 internal experiments, applying it to drug development, supply-chain risk prediction, clinical trials, and sales and employee services.
Accelerating drug development
Predicting supply-chain risks
Streamlining clinical trials
Supporting sales and employee services